Luteal serum BDNF and HSP70 levels in women with premenstrual dysphoric disorder

European Archives of Psychiatry and Clinical Neuroscience

Volumn 263, Issue 8, 2013, Pages 685-693

  Oral, E ^a   Ozcan, H ^a   Kirkan, T S ^a   Askin, S ^a   Gulec, M ^a   Aydin, N ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Brain derived neurotrophic factor; Heat shock protein 70; Premenstrual dysphoric disorder; Premenstrual syndrome

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HEAT SHOCK PROTEIN 70;

ADULT; ARTICLE; CELLULAR STRESS RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY RECORD OF SEVERITY OF PROBLEMS SHORT FORM; DEPRESSION; DISEASE ASSOCIATION; DSM-IV; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATHOGENESIS; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGIC ASSESSMENT;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING; FEMALE; HSP72 HEAT-SHOCK PROTEINS; HUMANS; LUTEAL PHASE; PREMENSTRUAL SYNDROME; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84889602269     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-013-0398-z     Document Type: Article

References (107)

1. Silva CM, Gigante DP, Carret ML, Fassa AG (2006) Population study of premenstrual syndrome. Rev Saude Publica 40:47-56
2. Teng CT, Filho AH, Artes R, Gorenstein C, Andrade LH, Wang YP (2005) Premenstrual dysphoric symptoms amongst Brazilian college students: factor structure and methodological appraisal. Eur Arch Psychiatry Clin Neurosci 255:51-56
3. American Psychiatric Association (APA) (2000) Premenstrual dysphoric disorder. In: First MB (ed) Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR). APA, Washington DC, pp 771-774
4. Rapkin AJ, Winer SA (2009) Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness. Expert Rev Pharmacoecon Outcomes Res 9:157-170
5. Halbreich U (2004) The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder clinical procedures and research perspectives. Gynecol Endocrinol 19:320-334
6. Derman O, Kanbur NO, Tokur TE, Kutluk T (2004) Premenstrual syndrome and associated symptoms in adolescent girls. Eur J Obstet Gynecol Reprod Biol 116:201-206
7. Braverman PK (2007) Premenstrual syndrome and premenstrual dysphoric disorder. J Pediatr Adolesc Gynecol 20:3-12
8. Rapkin AJ, Mikacich JA (2008) Premenstrual syndrome and premenstrual dysphoric disorder in adolescents. Curr Opin Obstet Gynecol 20:455-463
9. Inoue Y, Terao T, Iwata N, Okamoto K, Kojima H, Okamoto T, Yoshimura R, Nakamura J (2007) Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests. Psychopharmacology 190:213-219
10. Batra NA, Seres-Mailo J, Hanstock C, Seres P, Khudabux J, Bellavance F, Baker G et al (2008) Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder. Biol Psychiatry 63:1178-1184
11. Cubeddu A, Bucci F, Giannini A, Russo M, Daino D, Russo N, Merlini S et al (2011) Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome. Psychoneuroendocrinology 36:523-553
12. Dereboy Ç, Dereboy IF, Yiǧitol F (1994) Psychometric data for the premenstrual assessment form: a cluster analytic study. Turk Psikiyatri Derg 5:83-90
13. Steiner M, Dunn EJ (1996) The psychobiology of female-specific mood disorders. Infertil Reprod Med Clin North Am 7:297-313
14. Rapkin AJ, Morgan M, Goldman N, Brann DW, Simone D, Mahesh VB (1997) Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 90:709-714
15. Majewska MD, Harrison R, Schwartz RD, Barker JL, Paul SM (1986) Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232:1004-1007
16. Smith SS, Gong QJ, Hsu FC, Markowitz RS, ffrench-Mullen JM, Li X (1998) GABA A receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature (London) 392:926-930
17. Majewska MD (1992) Neurosteroids: endogenous bimodal modulators of the GAUA-A receptor. Mechanism of action and physiological significance. Prog Neurobiol 38:379-395
18. Sousa A, Ticku MK (1997) Interaction of the neurosteroid DHEAS with the GABA-A receptor complex reveals that it may act via the picrotoxin site. J Pharmacol Exp Ther 282:827-833
19. Barde YA, Edgar D, Thoenen H (1982) Purification of a new neurotrophic factor from mammalian brain. EMBO J 1:549-553
20. Bartkowska K, Turlejski K, Djavadian RL (2010) Neurotrophins and their receptors in early development of the mammalian nervous system. Acta Neurobiol Exp 70:454-467
21. Dawbarn D, Allen SJ (2003) Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol 29:211-230
22. Alonso M, Vianna MR, Depino AM, Mello e Souza T, Pereira P, Szapiro G (2002) BDNF-triggered events in the rat hippocampus are required for both short and long term memory formation. Hippocampus 12:551-560
23. Berkinschtein P, Cammarota M, Igaz LM, Bevilaqua LR, Izquierdo I, Medina JH (2007) Persistence of long-term memory storage requires a late protein synthesis and BDNF dependent phase in the hippocampus. Neuron 53:261-277
24. Caraci F, Copani A, Ferdinando Nicoletti F, Drago F (2010) Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. Eur J Pharmacol 626:64-71
25. Gosselin RD, Suter MR, Ji RR, Decosterd I (2010) Glial cells and chronic pain. Neuroscientist 16:519-531
26. Grande I, Fries GR, Kunz M, Kapczinski F (2010) The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig 7:243-250
27. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109:143-148
28. Oliveira GS, Ceresér KM, Fernandes BS, Kauer-Sant'Anna M, Fries GR, Stertz L (2009) Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res 43:1171-1174
29. Minelli A, Zanardini R, Bonvicini C, Sartori R, Pedrini L, Gennarelli M, Bocchio-Chiavetto L (2011) BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. Eur Arch Psychiatry Clin Neurosci 261:323-329
30. Lee HY, Kim YK (2008) Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology 57:194-199
31. Tapia-Arancibia L, Rage F, Givalois L, Arancibia S (2004) Physiology of BDNF: focus on hypothalamic function. Rev Front Neuroendocrinol 25:77-107
32. Begliuomini S, Casarosa E, Pluchino N, Lenzi E, Centofanti M, Freschi L, Pieri M, Genazzani AD, Luisi S, Genazzani AR (2007) Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod 22:995-1002
33. Barbany G, Persson H (1992) Regulation of Neurotrophin mRNA Expression in the rat brain by glucocorticoids. Eur J Neurosci 4:396-403
34. Barbany G, Persson H (1993) Adrenalectomy attenuates kainic acid-elicited increases of messenger RNAs for neurotrophins and their receptors in the rat brain. Neuroscience 54:909-922
35. Bova R, Micheli MR, Qualadrucci P, Zucconi GG (1998) BDNF and trkB mRNAs oscillate in rat brain during the light-dark cycle. Brain Res Mol Brain Res 57:321-324
36. Schaaf MJ, de Jong J, de Kloet ER, Vreugdenhil E (1998) Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Res 813:112-120
37. Dolci C, Montaruli A, Roveda E, Barajon I, Vizzotto L, Grassi Zucconi G, Carandente F (2003) Circadian variations in expression of the trkB receptor in adult rat hippocampus. Brain Res 994:67-72
38. Li GC, Werb Z (1982) Correlation between synthesis of heat shock proteins and development of thermotolerance in Chinese hamster fibroblasts. Proc Natl Acad Sci USA 79:3218-3222
39. Calderwood SK, Xie Y, Wang X, Khaleque MA, Chou SD, Murshid A, Prince T, Zhang Y (2010) Signal transduction pathways leading to heat shock transcription. Sign Transduct Insights 2:13-24
40. Ellis RJ (2007) Protein misassembly: macromolecular crowding and molecular chaperones. Adv Exp Med Biol 594:1-13
41. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR (2006) Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31:164-172
42. Ciocca DR, Calderwood SK (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10:86-103
43. Calderwood SK, Stevenson MA, Murshid A (2012) Heat shock proteins, autoimmunity, and cancer treatment. Autoimmune Dis. doi: 10.1155/2012/486069
44. Kim JJ, Mandelli L, Lim S, Lim HK, Kwon OJ, Pae CU, Serretti A, Nimgaonkar VL, Paik IH, Jun TY (2008) Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. Eur Arch Psychiatry Clin Neurosci 258:239-244
45. Daugaard M, Rohde M, Jaattela M (2007) The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions. FEBS Lett 581:3702-3710
46. Powers MV, Workman P (2007) Inhibitors of the heat shock response: biology and pharmacology. FEBS Lett 581:3758-3769
47. Patury S, Miyata Y, Gestwicki JE (2009) Pharmacological targeting of the Hsp70 chaperone. Curr Top Med Chem 9:1337-1351
48. Brodsky JL, Chiosis G (2006) Hsp70 molecular chaperones: emerging roles in human disease and identification of small molecule modulators. Curr Top Med Chem 6:1215-1225
49. Plumier JC, Krueger AM, Currie RW, Kontoyiannis D, Kollias G, Pagoulatos GN (1997) Transgenic mice expressing the human inducible Hsp70 have hippocampal neurons resistant to ischemic injury. Cell Stress Chaperones 2:162-167
50. Yenari MA, Fink SL, Sun GH, Chang LK, Patel MK, Kunis DM, Onley D, Ho DY, Sapolsky RM, Steinberg GK (1998) Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann Neurol 44:584-591
51. Rajdev S, Hara K, Kokubo Y, Mestril R, Dillmann W, Weinstein PR, Sharp FR (2000) Mice overexpressing rat heat shock protein 70 are protected against cerebral infarction. Ann Neurol 47:782-791
52. Papadopoulos MC, Sun XY, Cao J, Mivechi NF, Giffard RG (1996) Over-expression of Hsp-70 protects astrocytes from combined oxygen-glucose deprivation. Neuroreport 7:429-432
53. Xu L, Giffard RG (1997) HSP70 protects murine astrocytes from glucose deprivation injury. Neurosci Lett 224:9-12
54. Hendrick JP, Hartl FU (1993) Molecular chaperone functions of heat-shock proteins. Annu Rev Biochem 62:349-384
55. Yenari MA, Giffard RG, Sapolsky RM, Steinberg GK (1999) The neuroprotective potential of heat shock protein 70 (HSP70). Mol Med Today 5:525-531
56. Endicott J, Nee J, Harrison W (2006) Daily record of severity of problems (DRSP): reliability and validity. Arch Womens Ment Health 9:41-49
57. Duman RS, Malberg J, Nakagawa S, D'Sa C (2000) Neuronal plasticity and survival in mood disorders. Biol Psychiatry 48:732-739
58. Oral E, Canpolat S, Yildirim S, Gulec M, Aliyev E, Aydin N (2012) Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder. Brain Res Bull 88:454-459
59. Gazal M, Motta LS, Wiener CD, Fernandes JC, Quevedo LA, Jansen K (2011) Brain-derived neurotrophic factor in post-partum depressive mothers. Neurochem Res 37(3):583-587
60. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM (1997) Antidepressant- like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56:131-137
61. Stutzmann GE, LeDoux JE (1999) GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs related to fear conditioning. J Neurosci 19:RC8
62. Madhav TR, Pei Q, Zetterstrom TS (2001) Serotonergic cells of the rat raphe nuclei express mRNA of tyrosine kinase B (trkB), the high-affinity receptor for brain derived neurotrophic factor (BDNF). Brain Res Mol Brain Res 93:56-63
63. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50:260-265
64. Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S (2005) Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 255:381-386
65. Singh M, Su C (2012) Progesterone, brain-derived neurotrophic factor and neuroprotection. Neuroscience. doi: 10.1016/j.neuroscience.2012.09.056
66. Su C, Cunningham RL, Rybalchenko N, Singh M (2012) Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (pgrmc1)-dependent ERK5 signaling. Endocrinology 153:4389-4400
67. Andréen L, Nyberg S, Turkmen S, van Wingen G, Fernández G, Bäckström T (2009) Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology 34:1121-1232
68. Fish EW, Faccidomo S, DeBold JF, Miczek KA (2001) Alcohol, allopregnanolone and aggression in mice. Psychopharmacology 4:473-483
69. Gulinello M, Gong QH, Li X, Smith SS (2001) Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat. Brain Res 1:55-66
70. Sundstrom I, Andersson A, Nyberg S, Ashbrook D, Purdy RH, Backstrom T (1998) Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 2:126-138
71. Miczek KA, DeBold JF, van Erp AM, Tornatzky W (1997) Alcohol, GABAA-benzodiazepine receptor complex, and aggression. Recent Dev Alcohol 13:139-171
72. Timby E, Balgard M, Nyberg S, Spigset O, Andersson A, Porankiewicz-Asplund J, Purdy RH, Zhu D, Backstrom T, Poromaa IS (2006) Pharmacokinetic and behavioral effects of allopregnanolone in healthy women. Psychopharmacology 186:414-424
73. Gourley SL, Debold JF, Yin W, Cook J, Miczek KA (2005) Benzodiazepines and heightened aggressive behavior in rats: reduction by GABA(A)/alpha(1) receptor antagonists. Psychopharmacology 178:232-240
74. Whitnall MH (1993) Regulation of the hypothalamic corticotropin releasing hormone neurosecretory system. Prog Neurobiol 40:573-629
75. Herbert J, Goodyer IM, Grossman AB, Hastings MH, de Kloet ER, Lightman SL, Lupien SJ, Roozendaal B, Seckl JR (2006) Do corticosteroids damage the brain? J Neuroendocrinol 18:393-411
76. Roca CA, Schmidt PJ, Altemus M, Deuster P, Danaceau MA, Putnam K, Rubinow DR (2003) Differential menstrual cycle regulation of hypothalamic-pituitary- adrenal axis in women with premenstrual syndrome and controls. J Clin Endocrinol Metab 88:3057-3063
77. Lee EE, Nieman LK, Martinez PE, Harsh VL, Rubinow DR, Schmidt PJ (2012) ACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement. J Clin Endocrinol Metab 97:1887-1896
78. Meyer M, Deniselle MC, Gargiulo-Monachelli G, Lima A, Roig P, Guennoun R, Schumacher M, De Nicola AF (2012) Progesterone attenuates several hippocampal abnormalities of the wobbler mouse. J Neuroendocrinol. doi: 10.1111/jne.12004
79. Su T-P, Schmidt PJ, Danaceau M, Murphy DL, Rubinow DR (1997) Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. J Clin Endocrinol Metab 82:1220-1228
80. Girdler SS, Straneva PA, Light KC, Pedersen CA, Morrow AL (2001) Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 49:788-797
81. Endicott J, Amsterdam J, Eriksson E, Frank E, Freeman E, Hirschfeld R, Ling F, Parry B, Pearlstein T, Rosenbaum J, Rubinow D, Schmidt P, Severino S, Steiner M, Stewart DE, Thys-Jacobs S (1999) Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gend Based Med 8:663-679
82. Landén M, Eriksson E (2003) How does premenstrual dysphoric disorder relate to depression and anxiety disorders? Depress Anxiety 17:122-129
83. Klatzkin RR, Lindgren ME, Forneris CA, Girdler SS (2010) Histories of major depression and premenstrual dysphoric disorder: evidence for phenotypic differences. Biol Psychol 84:235-247
84. Bhatnagar S, Dallman M (1998) Neuroanatomical basis for facilitation of hypothalamic-pituitary-adrenal responses to a novel stressor after chronic stress. Neuroscience 84:1025-1039
85. Bhatnagar S, Vining C (2003) Facilitation of hypothalamic-pituitary- adrenal responses to novel stress following repeated social stress using the resident/intruder paradigm. Horm Behav 43:158-165
86. Jaferi A, Nowak N, Bhatnagar S (2003) Negative feedback functions in chronically stressed rats: role of the posterior paraventricular thalamus. Physiol Behav 78:365-373
87. McEwen BS (1998) Protective and damaging effects of stress mediators. N Engl J Med 338:171-179
88. McEwen BS (2005) Glucocorticoids, depression and mood disorders: structural remodeling in the brain. Metabolism 54:20-23
89. Vyas A, Mitra R, Rao BS, Chattarji S (2002) Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 22:6810-6818
90. Naert G, Ixart G, Maurice T, Tapia-Arancibia L, Givalois L (2011) Brain-derived neurotrophic factor and hypothalamic-pituitary-adrenal axis adaptation processes in a depressive-like state induced by chronic restraint stress. Mol Cell Neurosci 46:55-66
91. Schulte-Herbrüggen O, Chourbaji S, Ridder S, Brandwein C, Gass P, Hörtnagl H, Hellweg R (2007) Stress-resistant mice overexpressing glucocorticoid receptors display enhanced BDNF in the amygdala and hippocampus with unchanged NGF and serotonergic function. Psychoneuroendocrinology 31:1266-1277
92. Daftary SS, Calderon G, Rios M (2012) Essential role of brain-derived neurotrophic factor in the regulation of serotonin transmission in the basolateral amygdala. Neuroscience 224:125-134
93. Lanfumey L, Mongeau R, Cohen-Salmon C, Hamon M (2008) Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev 32:1174-1184
94. Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21:55-89
95. DeFranco DB (2000) Role of molecular chaperones in subnuclear trafficking of glucocorticoid receptors. Kidney Int 57:1241-1249
96. Pratt WB, Galigniana MD, Harrell JM, DeFranco DB (2004) Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement. Cell Signal 16:857-872
97. Kregel KC (2002) Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. J Appl Physiol 92:2177-2186
98. Kultz D (2005) Molecular and evolutionary basis of the cellular stress response. Annu Rev Physiol 67:225-257
99. Grad I, Picard D (2007) The glucocorticoid responses are shaped by molecular chaperones. Mol Cell Endocrinol 275:2-12
100. Udelsman R, Blake MJ, Stagg CA, Holbrook NJ (1994) Endocrine control of stress-induced heat shock protein 70 expression in vivo. Surgery 115:611-616
101. Udelsman R, Blake MJ, Stagg CA, Li DG, Putney DJ, Holbrook NJ (1993) Vascular heat shock protein expression in response to stress. Endocrine and autonomic regulation of this age-dependent response. J Clin Invest 91:465-473
102. Lindquist S, Craig EA (1988) The heat-shock proteins. Annu Rev Genet 22:631-677
103. Parsell DA, Lindquist S (1993) The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Annu Rev Genet 27:437-496
104. Morimoto RI (2008) Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev 22:1427-1438
105. Thom M, Seetah S, Sisodiya S, Koepp M, Scaravilli F (2003) Sudden and unexpected death in epilepsy (SUDEP): evidence of acute neuronal injury using HSP-70 and c-Jun immunohistochemistry. Neuropathol Appl Neurobiol 29:132-143
106. Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, Tandon NN, Sun B (2000) Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 470:113-117
107. Moalem G, Gdalyahu A, Shani Y, Otten U, Lazarovici P, Cohen IR, Schwartz M (2000) Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J Autoimmun 15:331-345